相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer
Yang Qu et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity
Yonglin Chen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy
Marc T. Roth et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer
Mengmeng Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Triumph against cancer: invading colorectal cancer with nanotechnology
Preksha Vinchhi et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Rangarirai Makuku et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
Shima Makaremi et al.
BIOMEDICINES (2021)
Cancer Nanomedicine and Immune System-Interactions and Challenges
Suhana Ahmad et al.
FRONTIERS IN NANOTECHNOLOGY (2021)
Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling
Pernille M. Madsen et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk
Jimi Kim et al.
CLINICAL NUTRITION (2020)
TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models
Katherine Case et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer The Canadian Cancer Trials Group CO.26 Study
Eric X. Chen et al.
JAMA ONCOLOGY (2020)
Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
Stefan Forster et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
Anastasia Constantinidou et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
Juliane Medler et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer
Michael A. Morse et al.
ONCOLOGIST (2019)
Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
Karolina Okla et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial
Donald T. Weed et al.
FRONTIERS IN IMMUNOLOGY (2019)
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumab
Alexandre A. Jacome et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity
Eric M. Tam et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer
Hye Ryun Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao et al.
THERANOSTICS (2019)
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
David M. Peereboom et al.
JCI INSIGHT (2019)
Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer: Current Status, Recent Advances, and Future Directions
Saivaishnavi Kamatham et al.
CURRENT COLORECTAL CANCER REPORTS (2019)
Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Sujuan Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway
Tao Zhao et al.
ONCOLOGY LETTERS (2017)
Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2
Hongping Ba et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage
Fuqian Yang et al.
MOLECULAR MEDICINE REPORTS (2017)
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H. O'Neil et al.
PLOS ONE (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues
Michael Delacher et al.
NATURE IMMUNOLOGY (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
George D. Kalliolias et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
Ana Babic et al.
BRITISH JOURNAL OF CANCER (2016)
Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis
Dao Xuan Nguyen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer
Sabrin H. Albeituni et al.
JOURNAL OF IMMUNOLOGY (2016)
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
Pernille M. Madsen et al.
JOURNAL OF NEUROSCIENCE (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
Geoffrey S. Williams et al.
ONCOTARGET (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary et al.
VACCINES (2016)
Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients
Fan Yan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases
Boram Ham et al.
CANCER RESEARCH (2015)
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Alison M. Paterson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
Eunyoung Chun et al.
CELL REPORTS (2015)
A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer
Laurence Duvillard et al.
BMC CANCER (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Xin Hu et al.
JOURNAL OF IMMUNOLOGY (2014)
Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells
Shawn A. Mahmud et al.
NATURE IMMUNOLOGY (2014)
Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity
Johannes Polz et al.
IMMUNITY INFLAMMATION AND DISEASE (2014)
Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis
Martin Chopra et al.
CARCINOGENESIS (2013)
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+Tregs within the tumor microenvironment
Chindu Govindaraj et al.
CLINICAL IMMUNOLOGY (2013)
Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
Moshe Sade-Feldman et al.
IMMUNITY (2013)
TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2013)
Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis
Hong Nie et al.
NATURE MEDICINE (2013)
Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
Yoshiaki Okubo et al.
SCIENTIFIC REPORTS (2013)
Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules
Takanori So et al.
FRONTIERS IN IMMUNOLOGY (2013)
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Breaking the 'harmony' of TNF-α signaling for cancer treatment
S. P. Sasi et al.
ONCOGENE (2012)
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
Srinivas Nagaraj et al.
SEMINARS IN CANCER BIOLOGY (2012)
TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40
Ryoko Hamano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Tumor necrosis factor receptor cross-talk
Petrus J. W. Naude et al.
FEBS JOURNAL (2011)
Cytokine Induction of Tumor Necrosis Factor Receptor 2 Is Mediated by STAT3 in Colon Cancer Cells
Kathryn E. Hamilton et al.
MOLECULAR CANCER RESEARCH (2011)
TNF Activates a NF-κB-Regulated Cellular Program in Human CD45RA- Regulatory T Cells that Modulates Their Suppressive Function
Meital Nagar et al.
JOURNAL OF IMMUNOLOGY (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
Martfn A. Rivas et al.
EXPERIMENTAL CELL RESEARCH (2008)
Cutting edge:: TNFR-Shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators
Geertje J. D. van Mierlo et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Role of NF-κB and PI 3-kinase/Akt in TNF-α-induced cytotoxicity in microvascular endothelial cells
Zhu Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
X Valencia et al.
BLOOD (2006)
Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway
R Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: Role in endothelial cell migration and angiogenesis
S Pan et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice
E Mizoguchi et al.
GASTROENTEROLOGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
分享论文
